- Prospective single-center cohort of 78 enrolled postpartum patients, with 61 fully analyzed, comparing vaginal and scheduled cesarean delivery.
- Wrist-worn actigraphy was worn throughout hospitalization to measure inpatient sleep and activity, with delivery mode as the exposure.
- Sleep was poor in both groups (median sleep-bout 3.6 h), with similar efficiency and total sleep time; movement and fragmentation indices were lower after vaginal delivery but not after multiple-comparison correction.
- Cesarean patients had greater sedentary and light activity on days 0-2, which persisted after correction, though the authors state its clinical meaning is unknown.
Obstetric
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This pilot mixed-methods study surveyed staff at a high-volume Hanoi maternity hospital, analyzing 1268 responses to build an obstetric anesthesia needs assessment framework.
- The framework was developed iteratively in three phases (pre-visit, on-site, post-visit), with no comparator group.
- Neuraxial anesthesia provider access was reported by 66.4%, safety checklist use by 90%, and 71.8% described morbidity and mortality tracking as inconsistently used.
- Financial constraints (39%) and lack of interest (33.1%) were the main barriers, and the authors concluded the framework can identify locally supported quality improvement priorities, though transferability needs further testing.
- Retrospective population-based cohort of 52,118 women with singleton, term, cephalic labors in Slovenia (2015–2024), stratified by BMI <30 kg/m² (n=46,448) and ≥30 kg/m² (n=5,670).
- Compared intravenous remifentanil PCA with labor epidural analgesia using multivariable logistic regression adjusted for maternal and obstetric confounders.
- Remifentanil PCA was associated with lower intrapartum cesarean and operative vaginal delivery risk in both BMI strata (all P ≤ 0.001), but higher postpartum hemorrhage risk in both.
- Authors conclude neonatal morbidity was not increased, while noting residual confounding and selection bias and calling for prospective studies to confirm causality.
- Retrospective single-center case series of 25 open fetal myelomeningocele repairs performed in Peru between January 2017 and July 2025.
- Maternal anesthesia used a total intravenous protocol with target-controlled propofol and remifentanil guided by bispectral index, neuromuscular blockade, and intravenous uterine relaxants, rather than volatile agents.
- All 25 procedures were completed without volatile anesthetics; magnesium sulfate with nitroglycerin was used in 60% of cases, fetal bradycardia occurred in one case (4%), and no maternal pulmonary edema was reported.
- The authors conclude that total intravenous anesthesia combined with intravenous uterine relaxants was feasible in this series, and median gestational age at delivery was 36 weeks.
- Single-patient case report of a 31-year-old primigravida at 36 weeks with active Plasmodium falciparum malaria and a platelet count of 64,000/μL receiving labor remifentanil.
- Remifentanil was given as patient-controlled bolus doses of 0.14 and 0.18 μg/kg with a 2-minute lockout period.
- Category III fetal heart rate tracings occurred twice, five hours apart, without maternal side effects, and normalized within 10 minutes of discontinuation.
- The authors conclude that remifentanil can cause severe, rapidly reversible fetal heart rate changes, so prompt recognition and discontinuation matter when neuraxial analgesia is contraindicated.
- Single-centre prospective observational study of 50 Caesarean deliveries at a Dutch tertiary hospital between July and October 2025.
- Carbon footprint was estimated from life-cycle assessment data for disposables and active pharmaceutical ingredient inventory data for drugs.
- Mean footprint was 5.6 kg CO2-eq per delivery, with disposables making up 80% (4.5 kg) and pharmaceuticals 1.1 kg.
- The prepackaged neuraxial tray, syringes and warming blanket contributed most, and about 4% of the impact came from unused disposables.
- Retrospective single-center analysis of a Serbian teaching hospital's 2012–2025 obstetric anesthesia training partnership; 130 anesthesiologists from 41 hospitals in five countries attended.
- The intervention was an annual or biennial one-to-two-week hands-on and didactic school covering neuraxial techniques and truncal blocks, with no comparator group.
- Neuraxial cesarean use rose from 13.8% (2011) to 79.9% (2025), a 4.7% average annual rate of change, P = 0.006; labor analgesia rose from 2.0% to 14.1%, P < 0.001.
- The authors conclude the partnership supported local training capacity and that neuraxial use increased at this center during the study period.
- Retrospective cohort of 31,979 singleton deliveries at or after 28 weeks across two Chicago hospitals, March 2018 to February 2020.
- Anemia was defined as third-trimester Hb below 11 g/dL and graded by severity, and was examined against sociodemographic factors and delivery site.
- Third-trimester anemia affected 40.2% (12,841 patients), more often in non-Hispanic Black patients (53.3%) and lower-income neighborhood residents.
- Transfusion was associated with Hispanic ethnicity (aOR 1.62), Asian race (aOR 1.42), anemia severity, cesarean delivery and site, but not non-Hispanic Black race (aOR 1.10).
- Single case report of a 37-year-old woman at 36 weeks with preeclampsia with severe features and acute cardiopulmonary failure.
- Venoarterial ECMO was started as a bridge to cesarean delivery without systemic anticoagulation, and delivery began once target flow was reached.
- Ejection fraction was below 20%; cardiac function recovered over 48 hours, support was stopped on day 3, and she left intensive care on day 9.
- The authors support individualized delivery timing and venoarterial ECMO as rescue support in selected critically unstable patients.
- A nationwide retrospective Taiwanese cohort study (2001-22) compared 247 pregnancy-associated ECLS cases with about 3.97 million non-ECLS pregnancies and 2,112 nonpregnant women receiving ECLS.
- The main exposure was ECLS during pregnancy or the peripartum period, with amniotic fluid embolism and peripartum cardiomyopathy as leading indications.
- Maternal 42-day mortality was 41.3%, and beyond 42 days ECLS-exposed pregnancies had higher all-cause mortality (aHR 28.0, 95% CI 16.8-46.8) than non-ECLS pregnancies.
- The authors conclude that pregnancy-associated ECLS is rare but rising, and that survivors need multidisciplinary follow-up for cardiovascular, renal and psychiatric sequelae.
- Single-center retrospective study comparing vaginal delivery patients before (2018, n = 2666) and after (2023, n = 2316) implementation of a protocol.
- A standardized multimodal analgesic order set emphasizing non-opioid medications over rescue oxycodone was introduced.
- Unadjusted inpatient opioid administration fell from 40.85% to 5.87% (P < 0.001), and outpatient opioid prescriptions fell from 19.2% to 1.9% (P < 0.001).
- Among patients given opioids, mean dose fell by 11.2 mg morphine equivalents; adjusted models found White patients were 25% less likely than Black patients to receive inpatient opioids.
- Systematic review and meta-analysis of 11 randomized controlled trials (n = 810) testing exercise for pregnancy-related pelvic girdle pain.
- The review explored how exercise prescription parameters, such as supervision and core-focused programs, related to pain and function outcomes.
- Exercise significantly reduced pain (SMD -0.81; 95% CI -1.06 to -0.55) and improved function (SMD -0.69; 95% CI -1.01 to -0.37), with moderate certainty.
- Limited subgroup data suggested supervised abdominopelvic core exercise may have larger effects, but these findings had substantial heterogeneity and very low to moderate certainty.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
- Randomised, double-blind, placebo-controlled two-centre trial of 58 analysed women undergoing Caesarean delivery under spinal anaesthesia.
- Compared bilateral lateral QLB with 20 ml 0.5% ropivacaine, intrathecal morphine 100 μg with sham block, or both combined.
- Noninferiority of QLB versus ITM for QoR-40 at 24 h was inconclusive (mean difference -0.9; 90% CI -0.9 to 13.5), while QLB reduced resting pain at 6 h versus ITM (MD 2.9, 95% CI 1.3 to 4.5; P<0.001).
- ITM+QLB further reduced early resting and coughing pain and worst pain at 24 h versus ITM alone, and pruritus was more frequent with QLB-containing groups but mostly mild.
- Single-center retrospective cohort of 12 cesarean deliveries in 11 women with Fontan circulation at a Japanese tertiary center, 2009-2025.
- Neuraxial anesthesia and cesarean delivery, with hemodynamics tracked before and after anesthesia and around delivery, and vasopressor support given as needed.
- After neuraxial anesthesia, CVP fell from 17.0 to 11.0 mmHg (-6.0 [-8.5 to -4.0], p = 0.006) and SBP fell from 129 to 107 mmHg; vasopressors avoided clinically significant hypotension in 11 of 12 deliveries.
- Postoperative arrhythmias occurred in 25% of deliveries, and no intraoperative heart failure or treatment-requiring arrhythmias were reported; the authors describe the fluctuations as manageable with CVP monitoring and pharmacologic support.
- This narrative review synthesizes current evidence on GLP-1 and dual GLP-1/GIP receptor agonists for obstetric and gynecologic practice, with a focus on women's health.
- Phase 3 trials report 15-21% body weight reduction, with tirzepatide described as superior to semaglutide, and PCOS meta-analyses report improved insulin resistance, androgen levels, and ovulation rates.
- Manufacturer guidance advises backup contraception for 4 weeks after tirzepatide initiation or dose escalation, because the drug significantly delays gastric emptying.
- Early human cohort studies of inadvertent early pregnancy exposure report no increased risk of major congenital malformations, which the authors describe as preliminary reassurance.
- Single-center retrospective observational study of 15 cesarean deliveries in 13 women with Fontan circulation.
- Compared neuraxial anesthesia (7 cases) with general anesthesia (8 cases), with prophylactic dopamine given to 7 and 5 patients respectively.
- No hypotension occurred under neuraxial anesthesia, whereas 6 patients receiving general anesthesia had transient hypotension treated with vasoactive agents.
- Heart failure needing diuretics developed in 7 patients (3 general, 4 neuraxial); the authors say either approach may be feasible but urge caution given the small sample.
- This consensus guideline combined a literature review of 239 identified articles (39 full-text) with a three-round modified Delphi involving 32 experts and one patient representative.
- The guideline addressed aseptic practice for single-shot spinal anaesthesia, with the routine sterile gown as the key question for uncomplicated adult patients.
- Consensus was reached on eight statements and 11 recommendations, including that routine sterile gown use should not be considered mandatory, while two statements did not reach consensus.
- The authors conclude that core measures such as hand hygiene and facemask use are essential, supporting a proportionate, sustainable approach to infection prevention.
- Umbrella review pooling 7 meta-analyses, 2 systematic reviews, 26 randomised trials and 15 observational studies on induction drugs for general anaesthesia at caesarean delivery.
- Compared drug classes used at induction: opioids, hypnotics (propofol versus thiopental), pressor-response attenuators, and neuromuscular blockers (rocuronium versus suxamethonium).
- Moderate-quality evidence suggested short-acting opioids gave maternal haemodynamic benefit without negative neonatal consequences, and rocuronium at ≥1 mg/kg gave intubation conditions comparable to suxamethonium.
- Authors concluded propofol is a preferred induction agent and rocuronium a suitable alternative to suxamethonium, though low-quality evidence supported propofol's lower risk of maternal accidental awareness.
- Double-blind RCT of 220 nulliparous parturients randomized to epidural labor analgesia with warmed (37°C) or room-temperature (22°C) local anesthetic solution.
- Both groups received 0.075% ropivacaine with 0.5 µg/mL sufentanil, differing only in solution temperature.
- Intrapartum fever occurred in 15.5% warmed versus 30.9% room-temperature (RR 0.5, 95% CI 0.298-0.840; P = .007), short of the prespecified 60% reduction target.
- Median maximum temperature was modestly lower in the warmed group, while shivering and all secondary outcomes did not differ significantly.